Your browser doesn't support javascript.
loading
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
Raizada, Neeraj; Sachdeva, K S; Sreenivas, Achuthan; Vadera, Bhavin; Gupta, R S; Parmar, Malik; Kulsange, Shubhangi; Babre, Ameet; Thakur, Rahul; Gray, Christen; Ramachandran, Ranjani; Alavadi, Umesh; Ghedia, Mayank; Vollepore, Balasangameshwara; Dewan, Puneet; Boehme, Catharina; Paramsivan, C N.
Afiliación
  • Raizada N; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Sachdeva KS; Central TB Division, Government of India, New Delhi, India.
  • Sreenivas A; World Health Organization, India Country Office, New Delhi, India.
  • Vadera B; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Gupta RS; Central TB Division, Government of India, New Delhi, India.
  • Parmar M; World Health Organization, India Country Office, New Delhi, India.
  • Kulsange S; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Babre A; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Thakur R; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Gray C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Ramachandran R; World Health Organization, India Country Office, New Delhi, India.
  • Alavadi U; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Ghedia M; World Health Organization, India Country Office, New Delhi, India.
  • Vollepore B; Foundation for Innovative New Diagnostics, New Delhi, India.
  • Dewan P; World Health Organization, India Country Office, New Delhi, India.
  • Boehme C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Paramsivan CN; Foundation for Innovative New Diagnostics, New Delhi, India.
PLoS One ; 9(2): e89301, 2014.
Article en En | MEDLINE | ID: mdl-24586675
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Ácidos Nucleicos / Tuberculosis Resistente a Múltiples Medicamentos / Atención a la Salud Tipo de estudio: Prognostic_studies / Sysrev_observational_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: India
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Ácidos Nucleicos / Tuberculosis Resistente a Múltiples Medicamentos / Atención a la Salud Tipo de estudio: Prognostic_studies / Sysrev_observational_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: India